Christopher Ogden - Net Worth and Insider Trading

Christopher Ogden Net Worth

The estimated net worth of Christopher Ogden is at least $1 Million dollars as of 2026-08-13. Christopher Ogden is the CFO of CytomX Therapeutics Inc and owns about 295,324 shares of CytomX Therapeutics Inc (CTMX) stock worth over $1 Million. Details can be seen in Christopher Ogden's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Christopher Ogden has not made any transactions after 2026-06-15 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Christopher Ogden

To

Are these stocks worth buying? — GuruFocus analysis for each holding

Christopher Ogden Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Christopher Ogden owns 1 companies in total, including CytomX Therapeutics Inc (CTMX) .

Click here to see the complete history of Christopher Ogden’s form 4 insider trades.

Insider Ownership Summary of Christopher Ogden

Ticker Company Transaction Date Type of Owner
CTMX CytomX Therapeutics Inc 2026-06-15 SVP & Finance and Accounting

Christopher Ogden Latest Holdings Summary

Christopher Ogden currently owns a total of 1 stock. Christopher Ogden owns 295,324 shares of CytomX Therapeutics Inc (CTMX) as of June 15, 2026, with a value of $1 Million.

Latest Holdings of Christopher Ogden

Ticker Company Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CTMX CytomX Therapeutics Inc 2026-06-15 295,324 3.49 1,030,681

Holding Weightings of Christopher Ogden


Christopher Ogden Form 4 Trading Tracker

According to the SEC Form 4 filings, Christopher Ogden has made a total of 8 transactions in CytomX Therapeutics Inc (CTMX) over the past 5 years, including 0 buys and 8 sells. The most-recent trade in CytomX Therapeutics Inc is the sale of 1,624 shares on June 15, 2026, which brought Christopher Ogden around $4,953.

Insider Trading History of Christopher Ogden

* The information on this page (including Insider Trading Shares, Share Changes, Cost, etc.) is sourced exclusively from Form 4 filings and does not incorporate any data from 13F or 13D/G filings. As a result, it may differ from the values shown on the Guru page.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Christopher Ogden Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Get the full picture on these stocks
See GF Score, valuation, financials, and warning signs for every stock Christopher Ogden owns.
View CTMX Analysis

Christopher Ogden Ownership Network

Ownership Network List of Christopher Ogden

No Data

Ownership Network Relation of Christopher Ogden

Insider Network Chart


Christopher Ogden Owned Company Details

What does CytomX Therapeutics Inc do?

Who are the key executives at CytomX Therapeutics Inc?

Christopher Ogden is the SVP & Finance and Accounting of CytomX Therapeutics Inc. Other key executives at CytomX Therapeutics Inc include SVP & Chief Scientific Officer Marcia Belvin , Chief Medical Officer Yu-waye Chu , and director & President and CEO Sean A. Mccarthy .

CytomX Therapeutics Inc (CTMX) Insider Trades Summary

Over the past 18 months, Christopher Ogden made 4 insider transaction in CytomX Therapeutics Inc (CTMX) with a net sale of 41,753. Other recent insider transactions involving CytomX Therapeutics Inc (CTMX) include a net sale of 313,929 shares made by Sean A. Mccarthy , a net sale of 64,888 shares made by Marcia Belvin , and a net sale of 25,304 shares made by Yu-waye Chu .

In summary, during the past 3 months, insiders sold 1,624 shares of CytomX Therapeutics Inc (CTMX) in total and bought 0 shares, with a net sale of 1,624 shares. During the past 18 months, 456,077 shares of CytomX Therapeutics Inc (CTMX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 456,077 shares.

CytomX Therapeutics Inc (CTMX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

CytomX Therapeutics Inc Insider Transactions

No Available Data

Christopher Ogden Mailing Address

Above is the net worth, insider trading, and ownership report for Christopher Ogden. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Christopher Ogden's mailing address is: South San Francisco Ca 94080.